Response to furosemide in chronic renal insufficiency: Rationale for limited doses
β Scribed by Brater, D Craig; Anderson, Shirley A; Brown-Cartwright, Debbie
- Book ID
- 109843902
- Publisher
- Nature Publishing Group
- Year
- 1986
- Tongue
- English
- Weight
- 488 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0009-9236
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Imatinib mesylate is the gold standard treatment of chronic myeloid leukaemia (CML) and 400βmg/day is considered the standard dose. Although it is generally well tolerated, some patients require temporary drug discontinuation and permanent dose reduction because of haematological or non
A 67-yr-old man with chronic cardiopulmonary disease exhibited severe hepatic and moderately severe renal injury after short-term ingestion of therapeutic doses of acetaminophen (1 to 3 @day for 3 days). Drug metabolism and other studies, performed 5 mo after recovery from the acute insult, indicate